COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 432: Articles 4311-4320  | Next

An explanation for SARS-CoV-2 rebound after Paxlovid treatment
Perelson, A. S., Ribeiro, R. M., Phan, T.
10.1101/2023.05.30.23290747 — Posted: 2023-06-01
ECHOCARDIOGRAPHIC MANIFESTATIONS OF COVID 19 ILLNESS AND DEVELOPMENT OF PERSISTENT RV DYSFUNCTION AND PULMANARY HYPERTENSION AS A LONG TERM SEQUELAE OF COVID 19 ILLNESS: A STUDY AMONG PATIENTS OF SOUTH EAST ASIAN REGION
KUMAR, L., MAHLA, H., CHATURVEDI, N., SIDHU, N. S., KESHAV, M., SHARMA, S. M., BAGARHATTA, R., AGRAWAL, V. V., PATHAK, V., Meena, C. B., MAHESHWARI, D., MEENA, P., PACHAR, B. S., SHARMA, S. K., GAUTAM, D., CHOUDHARY, S., SHEKHAWAT, D.
10.1101/2023.05.26.23290622 — Posted: 2023-06-01
Prenatal SARS-CoV-2 infection alters postpartum human milk-derived extracellular vesicles
Chutipongtanate, S., Cetinkaya, H., Zhang, X., Kuhnell, D., Benefield, D., Haffey, W., Wyder, M., Patel, R., Conrey, S. C., Burrell, A. R., Langevin, S., Nommsen-Rivers, L., Newburg, D. S., Greis, K. D., Staat, M. A., Morrow, A. L.
10.1101/2023.06.01.543234 — Posted: 2023-06-01
Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice
Ullah, I., Escudie, F., Scandale, I., Gilani, Z., Gendron-Lepage, G., Gaudette, F., Mowbray, C., Fraisse, L., Bazin, R., Finzi, A., Mothes, W., Kumar, P., Chatelain, E., Uchil, P. D.
10.1101/2023.05.31.543159 — Posted: 2023-06-01
The HLA-II immunopeptidome of SARS-CoV-2
Weingarten-Gabbay, S., Chen, D.-Y., Sarkizova, S., Taylor, H. B., Gentili, M., Pearlman, L. R., Bauer, M. R., Rice, C. M., Clauser, K. R., Hacohen, N., Carr, S. A., Abelin, J. G., Saeed, M., Sabeti, P. C.
10.1101/2023.05.26.542482 — Posted: 2023-06-01
A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels
Markmann, A. J., Bhowmik, D. R., Jiang, B., Van Hoy, M., Wang, F., Hou, Y. J., Baric, R. S., de Silva, A. M., Bartelt, L. A.
10.1101/2023.05.30.542314 — Posted: 2023-06-01
CD4+ T-cell immunity of SARS-CoV-2 patients determine pneumonia development
Naito, E., Uchida, T., Yamasaki, S., Hashimoto, K., Miura, Y., Shiono, A., Kawamura, T., Mouri, A., Yamaguchi, O., Imai, H., Kaira, K., Nemoto, M., Mitsutake, K., Nagata, M., Kagamu, H.
10.1101/2023.05.31.543129 — Posted: 2023-06-01
Universal features of Nsp1-mediated translational shutdown by coronaviruses
Schubert, K., Karousis, E. D., Ban, I., Lapointe, C., Leibundgut, M., Baeumlin, E., Kummerant, E., Scaiola, A., Schoenhut, T., Ziegelmueller, J., Puglisi, J., Muehlemann, O., Ban, N.
10.1101/2023.05.31.543022 — Posted: 2023-06-01
Stroke Hospitalization Administration & Monitoring: Routine Or Covid-19 Care (SHAMROCC)
Langlois-Therien, T., Shamy, M., Dewar, B., Ramsay, T., Lun, R., Blacquiere, D., Dowlatshahi, D., Stotts, G., Fahed, R., Ducroux, C.
10.1101/2023.05.29.23290701 — Posted: 2023-05-31
Infection by SARS-CoV-2 with alternate frequencies of mRNA vaccine boosting for patients undergoing antineoplastic treatment for cancer
Townsend, J. P., Hassler, H., Emu, B., Dornburg, A.
10.1101/2023.05.25.23290402 — Posted: 2023-05-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).